Abstract
While we most often relate antibiotic chemotherapy to erradication of infectious foreign organisms, we must remain aware of the value of antibiotics (e.g. anthracyclines, bleomycin, actinomycin D, mitomycin C, mithramycin, L-asparaginase) as antitumor drugs [5, 12]. Moreover, fermentation products continue to represent a fruitful field for discovering new materials with clinical anticancer potential. During 1976, the Division of Cancer Treatment (DCT), National Cancer Institute (NCI) examined over 1000 fermentation broths for activity against one or more animal tumors. The yield of “active” materials from this in vivo screening program are presented elsewhere in this volume [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Corbett, T. H., Griswold, D. P., jr., Roberts, B. J., Peckham, J. C., Schabel, F. M., jr.: Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinoma. Cancer (in press).
Douros, J.: Present National Cancer Institutes Fermentation Development Program. (See Chapter 4 of this book.)
Geran, R. I., Greenberg, N. H., Macdonald, M. M., Schumacher, A. M., Abbott, B. J.: Protocols for screening chemical agents and natural products against animal tumors and other biological systems (Third Edition). Cancer Chemother. Rep. Part 3, 3 (2), 1–5 (1972).
Goldin, A., Serpick, A. M., Mantel, N.: A commentary. Experimental screening procedures and clinical predictability value. Cancer Chemother. Rep. 50, 173–218 (1966).
Holland, J. F., Frei, E. (Eds.): Cancer Medicine. Philadelphia: Lea and Febiger 1973.
See Umezawa, H.: Principles of antitumor antibiotic chemotherapy, 817–826;
Dimarco, A., Lenaz, L.: Daunomycin and Adriamycin, 826–835;
Friedman, P. A., Cerami, A.: Actinomycin, 835–839;
Capizzi, R. L., Handschumacher, R. E.: Asparaginase, 850–859;
Goldin, A., Carter, S. K: Screening and evaluation of antitumor agents, 605–628.
Lippman, M. M., Laster, W. R., Abbott, B. J., Venditti, J. M., Baratta, M.: Antitumor activity of Macromomycin B (NSC-170105) against murine leukemias, melanoma, and lung carcinoma. Cancep Res. 35, 939–945 (1975).
Martin, D. S., Fugmann, R. A., Stolfi, R. L., Hayworth, P. E.: Solid tumor animal model therapeutically predictive for human breast cancer. Cancer Chemother. Rep. Part 2, 5 (1), 89–109 (1975).
Neil, G. L.: Detection and Assay of Antitumor Antibiotics. (See Chapter 2 of this book.)
Rosazza, J.: Antitumor Antibiotic Activation, Biotransformation and Derivation by Microbial Systems. (See Chapter 6 of this book.)
Venditti, J. M.: Forward in “Protocols for screening chemical agents and natural products against animal tumors and other biological systems (Third Edition)”. Cancer Chemother. Rep. Part 3, 3 (2), 1–5 (1972).
Venditti, J. M.: Drug evaluation branch program: Report to the screening contractors. Cancer Chemother. Rep. Part 2, 5 (1) 1–4 (1975).
Venditti, J. M.: Relevance of transplantable animal-tumor systems to the selection of new agents for clinical trial. In: Pharmacological Basis for Cancer Chemotherapy. Baltimore: Williams and Wilkins Co. 1975, pp. 245–270
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Venditti, J.M., Johnson, R.K. (1978). In Vivo Antitumor Evaluation of Antibiotics. Selected Results from the Drug Evaluation Program of the National Cancer Institute, U.S.A. In: Carter, S.K., Umezawa, H., Douros, J., Sakurai, Y. (eds) Antitumor Antibiotics. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 63. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81219-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-81219-4_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81221-7
Online ISBN: 978-3-642-81219-4
eBook Packages: Springer Book Archive